Summary of Ardent Health Q2 2026 Earnings Call

1Key Financial Results and Metrics

Revenue: $1.62 billion for Q2 2026.

Adjusted EBITDA: $115 million, with guidance reaffirmed for the full year at $485 million to $535 million.

Volume Trends: Surgeries and admissions declined by 2.9% and 1% year-over-year, respectively, with a notable recovery in June and July.

Operating Cash Flow: Strong performance at $197 million, up from $117 million in Q2 2025.

Labor Expenses: Salaries and benefits (SWB) grew only 0.7% year-over-year, with a 42% reduction in contract labor spend.

Debt and Liquidity: Total cash of $724 million and total debt of $1.1 billion, with a net leverage ratio of 0.8x.

2Strategic Updates and Business Highlights

IMPACT Program: A multiyear initiative aimed at operational excellence, with savings target increased to over $70 million for 2026.

Service Line Rationalization: Transitioning lower-margin procedures out of hospitals to focus on higher-margin service lines, such as cardiology and women's and children's health.

Payer Contracting: A disciplined, data-driven approach to renegotiate contracts, with a successful renewal expected to add $5 million to $10 million to adjusted EBITDA.

Technology Integration: Partnerships with Ensemble and Epic to enhance revenue cycle and clinical capabilities, and rollout of virtual care platforms showing early positive results.

3Forward Guidance and Outlook

Revenue Guidance: Biased towards the lower end of the $6.4 billion to $6.7 billion range due to weaker volume trends.

Adjusted EBITDA: Confidence in maintaining guidance despite volume headwinds, with expected improvements in Q3.

Market Position: Strong positioning in attractive markets growing faster than the U.S. average, with plans to capture additional market share.

4Bad News, Challenges, or Points of Concern

Volume Declines: Significant declines in surgeries and admissions during April and May, although there was a recovery in June and July.

Payer Mix Pressures: Increased self-pay volumes and exchange admissions declining 8% year-over-year, reflecting economic pressures on patients.

Uncertainty in Volume Recovery: Difficulty in predicting future volume trends due to macroeconomic factors and potential further declines in exchange coverage.

Operational Risks: Need for continued operational rigor and accountability to manage costs effectively in a challenging environment.

5Notable Q&A Insights

Payer Contracting Opportunities: Management indicated opportunities for improvement across most markets, emphasizing a more integrated approach to revenue cycle management.

Surgical Volume Dynamics: The decline in inpatient surgeries was attributed to shifts from inpatient to outpatient settings, with a modest economic impact.

Future Volume Expectations: Management remains cautiously optimistic about volume recovery, but is planning based on current run rates rather than June and July improvements.

Service Line Strategy: The focus on higher-margin service lines is expected to optimize surgical metrics, although the full impact will take time to materialize.

Exchange Coverage Trends: Management noted that while exchange attrition is a concern, many individuals are finding alternative coverage, which is more favorable than expected. This summary encapsulates the key points from the earnings call, providing a balanced view of Ardent Health's current financial health, strategic direction, and the challenges it faces moving forward.